|Post IPO Valuation|
|Venture Round, 11/2010 ||$10M|
|Venture Round, 12/2013 |
|Venture Round, 1/2014 |
Yelin Lapidot Investment House
Sphera Global Healthcare Master Fund
Migdal Insurance and Financial Holdings Ltd.
RedHill Biopharma, established in 2009, is a pharmaceutical company focused primarily on acquisition and development of late clinical-stage new, improved and patented formulations of existing drugs, with preference to a 505(b)(2)* regulatory paths, as well as acquisition and developement of late clinical-stage, new and patented orphan drugs.